Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05447806 · ClinicalTrials.gov registry record · NA
Diabetes Clinical Decision Support
A NA study of Diabetes and PreDiabetes, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 15,732
- Enrollment target
- 2
- Study locations
NCT05447806: Recruiting NA study of Diabetes and PreDiabetes, sponsored by Milton S. Hershey Medical Center.
NCT05447806 is a NA study of Diabetes and PreDiabetes that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 15,732 participants, above the 2,982-participant average among 338 other Diabetes trials with a reported enrollment target (428% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05447806, a NA study of Diabetes and PreDiabetes, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 15,732 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine the impact of an electronic medical record clinical decision support tool on rates of dysglycemia in the hospital, and its clinical and economical outcomes. The study also evaluates the perspectives of providers regarding the tool's usefulness on disease management support, knowledge, and practice performance.
Primary Outcome
Number of days in the hospital
Conditions Studied
Interventions
- DEVICE Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support
Study Locations (2)
Pennsylvania
- Penn State Hershey Medical Center - Hershey
- Penn State Health St. Joseph Medical Center - Reading
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,732 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT05447806 shows while recruiting
NCT05447806 is an interventional study that assigns participants to a tested intervention. Its 15,732 participants enrollment target places it among the larger protocols in the corpus, above the 2,982-participant average among 338 other Diabetes trials with a reported enrollment target (428% higher).
The record links to 5 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support is the first listed.
NCT05447806 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05447806 about?
NCT05447806 is a clinical study titled "Diabetes Clinical Decision Support". The purpose of this study is to determine the impact of an electronic medical record clinical decision support tool on rates of dysglycemia in the hospital, and its clinical and economical outcomes. The study also evaluates the perspectives of providers regarding the tool's usefulness on disease man...
What is the current status of trial NCT05447806?
This trial is currently recruiting. It is a NA study. The enrollment target is 15,732 participants. The study started on 2022-07-15. Estimated completion is 2026-05-31.
What conditions does trial NCT05447806 study?
This clinical trial studies the following conditions: Diabetes, PreDiabetes, Hypoglycemia, Hyperglycemia, Hyperglycemia Stress.
What interventions are being tested in trial NCT05447806?
The interventions under investigation include: Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support (DEVICE).
Who is sponsoring clinical trial NCT05447806?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05447806 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05447806's enrollment target sits among peer trials
15,732 10th of 338 higher than 329 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01737528 · 16,000 participants
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
- NCT06380114 · 16,000 participants · NA
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
- NCT07000357 · 15,100 participants · Phase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI